Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Creamy Kee's
- Development stage
- Unknown
- Lead developer
- Cannamedical Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation
01
Overview
Creamy Kee's is a medical cannabis flower product developed and distributed by Cannamedical Pharma, derived from the hybrid strain bred by the Super Sativa Seed Club (a cross of Karel's Haze and Cookies & Cream). It is available in various formulations such as CM 20/1 CRM, CM 24/1, and CM 28/1 CRM, containing approximately 20% to 28% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD). The strain is characterized by a terpene profile rich in beta-caryophyllene, beta-myrcene, and nerolidol, giving it a sweet, creamy, vanilla, and earthy aroma. It is prescribed for medical use, typically administered via inhalation using a medical vaporizer, to provide physical relaxation and mental relief for conditions such as chronic pain, stress, anxiety, and sleep disorders.
- Brand names
- Creamy Kee's No. 5Creamy Kee's No. 6
- Other names
- Creamy KeesCreamy Kees No. 5Creamy Kees No. 6
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Creamy Kee's.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Creamy Kee's.